Menta Capital’s Cytosorbents Corp CTSO Stock Holding History

Menta Capital’s Portfolio CTSO Stock Details CTSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-10,576	Closed	-$80K	–	511
2019 Q1	$80K	Sell	10,576 -2,200	-17%	-$17.1K	0.03%	450
2018 Q4	$103K	Buy	+12,776	New	+$127K	0.04%	498
2018 Q3	–	Sell	-27,279	Closed	-$311K	–	586
2018 Q2	$311K	Buy	27,279 +9,240	+51%	+$87.5K	0.07%	464
2018 Q1	$127K	Buy	+18,039	New	+$136K	0.03%	592

Other funds holding CTSO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

USAA

United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return

Menta Capital's CTSO Position: Q2 2019 in Review

Menta Capital sold out of Cytosorbents Corp (CTSO) in Q2 2019, closing a stake of 10,576 shares — an estimated $80K sold.

Menta Capital first reported a position in CTSO in Q1 2018 and held it in 4 quarters. The position peaked at $311K in Q2 2018. 72 funds tracked by Wall St. Rank hold CTSO as of Q2 2019.

Menta Capital reported no remaining Cytosorbents Corp position as of Q2 2019 after selling out during the quarter.
Menta Capital sold 10,576 Cytosorbents Corp shares in Q2 2019, an estimated $80K.
Menta Capital first reported a position in Cytosorbents Corp in Q1 2018 and held it in 4 quarters.
Menta Capital's Cytosorbents Corp position peaked at $311K in Q2 2018.
72 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2019.

Based on Menta Capital's 13F filing for Q2 2019, filed 7 Aug 2019.